Pure Global

Anti Cardiolipin IgM - India CDSCO Medical Device Registration

Anti Cardiolipin IgM is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000022_9f8f66b04f3280cc72a8688a3aa3ddf4_b4014450c9a8ddfd15fc20c932332326. This device is marketed under the brand name Merilisa. The license holder is Meril Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Gujarat.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Anti Cardiolipin IgM
UID: MFG/MD/2018/000022_9f8f66b04f3280cc72a8688a3aa3ddf4_b4014450c9a8ddfd15fc20c932332326

Brand Name

Merilisa

Device Class

Class B

Approving Authority

Gujarat

Product Information

Anti Cardiolipin IgM is an indirect solid phase immunoassay kit for the quantitative measurement of IgM class autoantibodies directed against Cardiolipina-ฮฒ2-glycoprotein complex in human serum or plasma. The assay is intended for in vitro diagnostic use only as an aid in the diagnosis of increased risk of thrombosis in patients with Systemic Lupus Eritematosus (Merilisa) or similar disorders. Anti Cardiolipin IgM kit is intended for laboratory use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing